Costimulation blockade inhibits the indirect pathway of allorecognition in nerve allograft rejection

Muscle and Nerve

Volumn 43, Issue 1, 2011, Pages 120-126

  Ray, Wilson Z ^a   Kasukurthi, Rahul ^a   Kale, Santosh S ^a   Santosa, Katherine B ^a   Hunter, Daniel A ^a   Johnson, Philip ^a   Yan, Ying ^a   Mohanakumar, Thalachallour ^a   MacKinnon, Susan E ^a   Tung, Thomas H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allograft; Blockade; Cold preservation; Costimulatory; Immunosuppression; Peripheral nerve

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; IMMUNOMODULATING AGENT;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DONOR; GRAFT RECIPIENT; GRAFT REJECTION; HYPOTONIC HYPORESPONSIVE EPISODE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MORPHOMETRICS; MOUSE; NERVE GRAFT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL CELL; COSTIMULATION BLOCKADE; NERVE ALLOGRAFT; NERVE BLOCK; NERVE REGENERATION; NERVE TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, BLOCKING; AXONS; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS II; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE REGENERATION; PERIPHERAL NERVES; SCIATIC NEUROPATHY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 78650474617     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21807     Document Type: Article

References (44)

1. Gulati AK. Immune response and neurotrophic factor interactions in peripheral nerve transplants. Acta Haematol 1998;99:171-174.
2. Gulati AK, Cole GP. Nerve graft immunogenicity as a factor determining axonal regeneration in the rat. J Neurosurg 1990;72:114-122.
3. Lassner F, Schaller E, Steinhoff G, Wonigeit K, Walter GF, Berger A. Cellular mechanisms of rejection and regeneration in peripheral nerve allografts. Transplantation 1989;48:386-392.
4. MacKinnon S, Hudson A, Falk R, Bilbao J, Klein D, Hunter D. Nerve allograft response: a quantitative immunological study. Neurosurgery 1982;10:61-69.
5. Pollard JD, Gye RS, McLeod JG. An assessment of immunosuppressive agents in experimental peripheral nerve transplantation. Surg Gynecol Obstet 1971;132:839-845.
6. Trumble TE, Shon FG. The physiology of nerve transplantation. Hand Clin 2000;16:105-122.
7. Yu LT, Rostami A, Silvers WK, Larossa D, Hickey WF. Expression of major histocompatibility complex antigens on inflammatory peripheral nerve lesions. J Neuroimmunol 1990;30:121-128.
8. Auchincloss H Jr, Sultan H. Antigen processing and presentation in transplantation. Curr Opin Immunol 1996;8:681-687.
9. Gould DS, Auchincloss H Jr. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 1999;20:77-82.
10. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994;15:32-38.
11. Yamada A, Chandraker A, Laufer TM, Gerth AJ, Sayegh MH, Auchincloss H Jr. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J Immunol 2001;167:5522-5526.
12. Auchincloss H Jr, Ghobrial RR, Russell PS, Winn HJ. Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo. Transplantation 1988;45:1118-1123.
13. Ghobrial RR, Boublik M, Winn HJ, Auchincloss H Jr. In vivo use of monoclonal antibodies against murine T cell antigens. Clin Immunol Immunopathol 1989;52:486-506.
14. Hunter DA, Moradzadeh A, Whitlock EL, Brenner MJ, Myckatyn AL, Wei CH, et al. Binary imaging analysis for comprehensive quantitative histomorphometry of peripheral nerve. J Neurosci Methods 2007;166:116-124.
15. Guillonneau C, Aubry V, Renaudin K, Séveno C, Usal C, Tezuka K, et al. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation 2005;80:546-554.
16. Guillonneau C, Séveno C, Dugast AS, Li XL, Renaudin K, Haspot F, et al. Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients. J Immunol 2007;179:8164-8171.
17. Metzler B, Gfeller P, Biguad M, Li J, Wieczorek G, Huesser C, et al. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection. J Immunol 2004;173:7025-7036.
18. Kvist M, Kanje M, Ekberg H, Corbascio M, Dahlin LB, et al. Costimulation blockade in transplantation of nerve allografts: long-term effects. J Peripher Nerv Syst 2008;13:200-207.
19. Kvist M, Lemplesis V, Kanje M, Ekberg H, Corbascio M, Dahlin LB. Immunomodulation by costimulation blockade inhibits rejection of nerve allografts. J Peripher Nerv Syst 2007;12:83-90.
20. Ray WZ, Kasukhurthi R, Papp EM, Moore AM, Yee EA, Hunter DA, et al. The role of T helper cell differentiation in promoting nerve allograft survival with costimulation blockade. J Neurosurg 2010;112:386-393.
21. MacKinnon SE, Midha R, Bain J, Hunter D, Wade J. An assessment of regeneration across peripheral nerve allografts in rats receiving short courses of cyclosporin A immunosuppression. Neuroscience 1992;46:585-593.
22. Midha R, Evans PJ, MacKinnon SE, Wade JA. Temporary immunosuppression for peripheral nerve allografts. Transplant Proc 1993;25:532-536.
23. Midha R, MacKinnon SE, Becker LE. The fate of Schwann cells in peripheral nerve allografts. J Neuropathol Exp Neurol 1994;53:316-322.
24. Atchabahian A, Genden EM, MacKinnon SE, Doolabh VB, Hunter DA. Regeneration through long nerve grafts in the swine model. Microsurgery 1998;18:379-382.
25. Foster RD, Pham S, Li S, Aitouche A. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Transplantation 2003;76:988-994.
26. Gao W, Demirci C, Strom TB, Li XC. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces longterm islet allograft survival. Transplantation 2003;76:994-999.
27. Kosuge H, Suzuki J, Gotoh R, Koga N, Ito H, Isobe M, et al. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway. Transplantation 2003;75:1374-1379.
28. Lakkis FG, Konieczny BT, Saleem S, Baddoura SK, Linsley PS, et al. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J Immunol 1997;158:2443-2448.
29. Larsen CP, Knechtle SJ, Adams A, Pearson T, Kirk AD. A new look at blockade of T-cell costimulation: a therapeutic strategy for longterm maintenance immunosuppression. Am J Transplant 2006;6:876-883.
30. Vincenti F, Larsen C, Durrboch A, Wekerle T, Nashan B, Blancho G, et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005;353:770-781.
31. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996;381:434-438.
32. van Maurik A, Herber M, Wood KJ, Jones ND. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 2002;169:5401-5404.
33. Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995;182:459-465.
34. Walunas TL, Lenshcow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994;1:405-413.
35. Kita Y, Li XK, Ohba M, Funeshima N, Enosawa S, Tamura A, et al. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene. Transplantation 1999;68:758-766.
36. Turka LA, Linsley PS, Lin H, Brady W, Leiden GM, Wi RQ, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992;89:11102-11105.
37. Dong C, Juedes EA, Temann UA, Shresta S, Allison JP, Ruddle NH, et al. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 2001;409:97-101.
38. McAdam AJ, Schweitzer AN, Sharpe AH. The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol Rev 1998;165:231-247.
39. Pan XC, Guo L, Deng YB, Naruse K, Kimura H, Sugawara Y, et al. Further study of anti-ICOS immunotherapy for rat cardiac allograft rejection. Surg Today 2008;38:815-825.
40. Guo L, Li XK, Enosawa S, Funeshima N, Suzuki S, Kimura H, et al. Significant enhancement by anti-ICOS antibody of suboptimal tacrolimus immunosuppression in rat liver transplantation. Liver Transplant 2004;10:743-747.
41. Tai CY, Weber RV, MacKinnon SE, Tung TH. Multiple costimulatory blockade in the peripheral nerve allograft. Neurol Res 2010;32:332-6.
42. Auchincloss H Jr, Lee R, Shay S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993;90:3373-3377.
43. Phillips NE, Grenier DL, Mordis JP, Rossini AA. Costimulatory blockade induces hyporesponsiveness in T cells that recognize alloantigen via indirect antigen presentation. Transplantation 2006;82:1085-1092.
44. Rulifson IC, Szot GL, Palmer E, Bluestone JA. Inability to induce tolerance through direct antigen presentation. Am J Transplant 2002;2:510-519.